When.com Web Search

  1. Ads

    related to: what is janumet used for

Search results

  1. Results From The WOW.Com Content Network
  2. Sitagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Sitagliptin/metformin

    In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...

  3. Sitagliptin - Wikipedia

    en.wikipedia.org/wiki/Sitagliptin

    Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. [8] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. [9] It is taken by mouth. [8] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet ...

  4. Metformin - Wikipedia

    en.wikipedia.org/wiki/Metformin

    The US Food and Drug Administration (FDA) recommends avoiding the use of metformin in more severe chronic kidney disease, below the eGFR cutoff of 30 mL/minute/1.73 m 2. [94] Lactate uptake by the liver is diminished with metformin use because lactate is a substrate for hepatic gluconeogenesis, a process that metformin

  5. 2 Red Flags for Merck's Type 2 Diabetes Blockbuster - AOL

    www.aol.com/2013/05/20/2-red-flags-for-mercks...

    In the following video, Fool contributor Maxxwell Chatsko provides an update on the outlook of Merck's best-selling type 2 diabetes drug franchise of Januvia/Janumet. While the franchise reeled in ...

  6. Medicare announces weight-loss drugs, including Ozempic ... - AOL

    www.aol.com/news/medicare-announces-15-drugs...

    Janumet; Janumet XR, diabetes drugs. Otezla, a psoriatic arthritis drug. ... About 5.3 million people on Medicare used the drugs between Nov. 1, 2023, and Oct. 1, 2024, according to the CMS. ...

  7. Medicare targets popular weight loss drugs Ozempic, Wegovy ...

    www.aol.com/medicare-targets-popular-weight-loss...

    About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $41 billion to the government-funded health program ...